Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Semin Cancer Biol. 2015 May 5;35 Suppl:S151–S184. doi: 10.1016/j.semcancer.2015.03.006

Table II. Cross validation of Approaches.

Selected approaches evaluated for reported actions in other cancer hallmark areas.

Approach1 Curcumin Resveratrol EGCG Lycopene Anthocyanins Genistein

Other Hallmarks
Genomic Instability + [770] + [682] + [771] + [772] + [770] + [773]
Sustained Proliferative Signaling + [774] + [775777] + [678, 778] + [488, 779] + [780, 781] +/− [782, 783]
Evasion of Anti-growth Signaling + [784, 785] + [786, 787] + [788, 789] + [790792] + [793] +/− [544, 794, 795]
Resistance to Apoptosis + [796] + [797] + [798] + [799] + [800] + [518]
Replicative Immortality + [774, 801, 802] + [803, 804] + [805, 806] 0 + [807] + [808, 809]
Deregulated Metabolism + [810] + [811, 812] + [813815] 0 0 +/− [816]
Immune System Evasion + [371] +/− [425, 817819] + [820] 0 0 +/− [554, 821]
Angiogenesis + [822] +/− [823] + [824] + [825] + [826] + [827]
Tissue Invasion and Metastasis + [774, 828] + [829] + [312, 830, 831] + [832] + [833] + [830]
Tumor Microenvironment + [834, 835] + [836, 837] + [820, 838] + [772, 839] + [840] + [841]
1

Approaches that were found to have complementary, anticarcinogenic actions in a particular hallmark area were were indicated with “+”, while approaches that were found to have procarcinogenic actions in a particular hallmark area were indicated with “ −”. In instances where reports on relevant actions in other hallmarks were mixed (i.e., reports showing both anticarcinogenic and procarcinogenic potential), the symbol “+/−“ was used. Finally, in instances where no literature support was found to document the relevance of an approach in a particular aspect of cancer's biology, we documented this as “0”'. Threse cross-hallmark relationships are reported in the first eleven columns of the table. Finally, the number of anticarcinogenic, procarcinogenic and mixed cross-hallmark relationships for each target have been summed and are reported in the last three columns of the table.

HHS Vulnerability Disclosure